Our Board of Directors
Steering progress with integrity and vision: Meet Sutura’s Board of Directors.
Thomas has extensive experience in biotech investment and advising growth companies, and brings a wealth of transactional and operational expertise to Sutura Therapeutics as a Non-Executive Director.
James Noble joined Sutura as Chairman in February 2020. He has held numerous senior executive positions and brings over 35 years of experience in the international biotechnology industry and investment banking.
Edwin brings his extensive experience in the translation and commercial development of innovative therapies to his role as CEO of Sutura, which includes specialised knowledge in advanced therapy medicinal products (ATMPs) and orphan drugs.
Dr. Volker Knappertz joined Sutura Therapeutics as Non-Executive Director in 2021. He is a recognised leader in the drug development community and has achieved numerous INDs and product approvals.
